As observed in some previously mentioned neurodegenerative diseases, intranasal insulin intervention significantly augmented the cognitive abilities of patients with MS, thus providing further supportive evidence of mechanism of the insulin resistance in patients with MS (Mowry et al., 2017). This evidence concerns the gene INS and myeloid sarcoma.